Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Bacterial Genome Recoded to Produce Stable Protein Drugs

E. coli bacteria

A biotechnology lab devised techniques for genetically engineered bacteria to produce synthetic proteins that can last longer and are more stable than current protein production methods. . . . → Read More: Bacterial Genome Recoded to Produce Stable Protein Drugs

Patent Awarded for Nasal Delivered Cancer Immunotherapy

U.S. Patent and Trademark Office

A technology for cancer therapies that harnesses the immune system with nanoscale droplets suspended in an emulsion and delivered through the nose received a U.S. patent. . . . → Read More: Patent Awarded for Nasal Delivered Cancer Immunotherapy

FDA Okays A.I.-Guided Wrist Fracture Software

Bones in the wrist and hand

The U.S. Food and Drug Administration authorized marketing of software to help diagnose wrist fractures using machine-learning algorithms to read and interpret X-ray images. . . . → Read More: FDA Okays A.I.-Guided Wrist Fracture Software

Infographic – Graphene Investment in Decline

Investments in graphene start-ups

In a report this week, our friends at CB Insights note that the investment community is waiting for graphene to reach a critical commercial mass, but their patience may be running out. . . . → Read More: Infographic – Graphene Investment in Decline

Univ. Licenses Barrett’s Esophagus Detection Device

Cancer magnified

A medical device company is licensing a minimally-invasive technology developed in university labs for detection of Barrett’s esophagus, a condition that often leads to esophageal cancer. . . . → Read More: Univ. Licenses Barrett’s Esophagus Detection Device

Genetic Repair Company Starts-Up, Gains $87 Million

David Liu

A company is getting underway to develop therapies that extend genome editing to repair genetic disruptions, not just remove them from DNA. . . . → Read More: Genetic Repair Company Starts-Up, Gains $87 Million

Genentech Gains Microbe Drug Discovery Tech in $1B Deal

Collecting soil samples

Biotechnology company Genentech is licensing a process from a start-up enterprise that discovers small molecule drugs from naturally occurring microbes found in soil. . . . → Read More: Genentech Gains Microbe Drug Discovery Tech in $1B Deal

New Cell Therapy Company Raises $58.5M in Early Funds

Investment graphic

A start-up enterprise is discovering therapies to address a variety of disorders that result from faulty cell degradation processes known as autophagy, which when functioning normally contribute to cell health. . . . → Read More: New Cell Therapy Company Raises $58.5M in Early Funds

Digital Drug Discovery Company Wins A.I. Competition

Full data screen

A company using artificial intelligence algorithms and big data analytics to discover drug targets from RNA splicing errors is the winner of a competition among start-up enterprises for innovative uses of A.I. technology. . . . → Read More: Digital Drug Discovery Company Wins A.I. Competition

Gene Therapy Biotech Acquired in $8.7 Billion Deal

A biotechnology enterprise developing gene therapies for rare inherited diseases and neurological disorders is being acquired by pharmaceutical company Novartis AG for $8.7 billion. . . . → Read More: Gene Therapy Biotech Acquired in $8.7 Billion Deal